• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

左炔诺孕酮宫内节育系统在青少年医学适应证中的应用。

Use of levonorgestrel intrauterine system for medical indications in adolescents.

机构信息

Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, Oregon 97239, USA.

出版信息

J Adolesc Health. 2013 Apr;52(4 Suppl):S54-8. doi: 10.1016/j.jadohealth.2012.09.022.

DOI:10.1016/j.jadohealth.2012.09.022
PMID:23535058
Abstract

The levonorgestrel intrauterine system (LNG-IUS) is an underused contraceptive method in adolescent populations. In addition to being a highly effective, reversible, long-acting contraception, the LNG-IUS has many noncontraceptive health benefits including reduced menstrual bleeding, decreased dysmenorrhea and pelvic pain related to endometriosis, and menstruation suppression in teens with physical or developmental disabilities. The LNG-IUS can also provide endometrial protection in teens with chronic anovulation, and may be used to treat endometrial hyperplasia and cancer. This review examines the evidence supporting the use of the LNG-IUS in adolescents for these noncontraceptive benefits.

摘要

左炔诺孕酮宫内节育系统(LNG-IUS)在青少年人群中的使用并不广泛。除了作为一种高效、可逆、长效的避孕方法外,LNG-IUS 还具有许多非避孕健康益处,包括减少月经出血、减轻与子宫内膜异位症相关的痛经和盆腔疼痛,以及抑制身体或发育障碍的青少年的月经。LNG-IUS 还可以为患有慢性无排卵的青少年提供子宫内膜保护,也可用于治疗子宫内膜增生和癌症。本文综述了支持 LNG-IUS 在青少年中用于这些非避孕益处的证据。

相似文献

1
Use of levonorgestrel intrauterine system for medical indications in adolescents.左炔诺孕酮宫内节育系统在青少年医学适应证中的应用。
J Adolesc Health. 2013 Apr;52(4 Suppl):S54-8. doi: 10.1016/j.jadohealth.2012.09.022.
2
Mirena (Levonorgestrel intrauterine system): a successful novel drug delivery option in contraception.曼月乐(左炔诺孕酮宫内节育系统):一种成功的新型避孕药物递送选择。
Adv Drug Deliv Rev. 2009 Aug 10;61(10):808-12. doi: 10.1016/j.addr.2009.04.022. Epub 2009 May 13.
3
The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis.左炔诺孕酮宫内缓释系统治疗子宫腺肌病的研究:一项关于使用左炔诺孕酮宫内系统治疗子宫腺肌病相关痛经的疗效和副作用的3年随访研究。
Contraception. 2009 Mar;79(3):189-93. doi: 10.1016/j.contraception.2008.11.004. Epub 2008 Dec 11.
4
Non-contraceptive health benefits of intrauterine hormonal systems.宫内激素系统的非避孕健康益处。
Contraception. 2010 Nov;82(5):396-403. doi: 10.1016/j.contraception.2010.05.005.
5
Added health benefits of the levonorgestrel contraceptive intrauterine system and other hormonal contraceptive delivery systems.增加了左炔诺孕酮避孕宫内节育系统和其他激素避孕输送系统的健康益处。
Contraception. 2013 Mar;87(3):273-9. doi: 10.1016/j.contraception.2012.08.039. Epub 2012 Oct 4.
6
Assessment of the use of two new low-dose levonorgestrel-releasing intrauterine systems as contraceptives.两种新型低剂量左炔诺孕酮宫内节育系统作为避孕药具的使用评估。
Womens Health (Lond). 2012 May;8(3):235-8. doi: 10.2217/whe.12.12.
7
Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS)--a systematic enquiry and overview.左炔诺孕酮释放激素系统(LNG-IUS)的非避孕用途——一项系统的调查与综述
Eur J Obstet Gynecol Reprod Biol. 2006 Mar 1;125(1):9-28. doi: 10.1016/j.ejogrb.2005.10.029. Epub 2005 Dec 1.
8
Use of the levonorgestrel intrauterine system in adolescents with endometriosis.左炔诺孕酮宫内节育系统在患有子宫内膜异位症的青少年中的应用。
J Pediatr Adolesc Gynecol. 2013 Apr;26(2):120-4. doi: 10.1016/j.jpag.2012.11.002.
9
The effect of intrauterine and oral levonorgestrel administration on serum concentrations of sex hormone-binding globulin, insulin and insulin-like growth factor binding protein-1.宫内及口服左炔诺孕酮对性激素结合球蛋白、胰岛素及胰岛素样生长因子结合蛋白-1血清浓度的影响。
Acta Obstet Gynecol Scand. 1999 May;78(5):423-8.
10
Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis.左炔诺孕酮宫内缓释系统和 T380A 宫内节育器对有和无子宫腺肌病妇女痛经和出血天数的影响。
Contraception. 2012 Nov;86(5):458-63. doi: 10.1016/j.contraception.2012.04.001. Epub 2012 Jul 24.

引用本文的文献

1
Utility of the Levonorgestrel-Releasing Intrauterine System in the Treatment of Abnormal Uterine Bleeding and Dysmenorrhea: A Narrative Review.左炔诺孕酮宫内节育系统在治疗异常子宫出血和痛经中的应用:一项叙述性综述。
J Clin Med. 2022 Oct 1;11(19):5836. doi: 10.3390/jcm11195836.
2
Medical and Behavioral Aspects of Adolescent Endometriosis: A Review of the Literature.青少年子宫内膜异位症的医学与行为学方面:文献综述
Children (Basel). 2022 Mar 9;9(3):384. doi: 10.3390/children9030384.
3
[Not Available].[无可用内容]。
CMAJ. 2021 Jul 19;193(28):E1114-E1115. doi: 10.1503/cmaj.201972-f.
4
Painful periods in adolescents.青少年的痛经
CMAJ. 2021 Apr 19;193(16):E560. doi: 10.1503/cmaj.201972.
5
Hormone treatment and UVB exposure influences on female mice regarding skin physiological parameters, biochemical parameters and organ histology.激素治疗和 UVB 照射对雌性小鼠皮肤生理参数、生化参数和器官组织学的影响。
Rom J Morphol Embryol. 2020 Jul-Sep;61(3):879-887. doi: 10.47162/RJME.61.3.26.
6
Contraceptive Practices and Reproductive Health Considerations for Adolescent and Adult Women with Intellectual and Developmental Disabilities: A Review of the Literature.智力和发育障碍的青少年及成年女性的避孕措施与生殖健康考量:文献综述
Sex Disabil. 2019 Oct;37(4):541-557. doi: 10.1007/s11195-019-09600-8.
7
Identifying and addressing gaps in reproductive health education for adolescent girls with type 1 diabetes.识别和弥补 1 型糖尿病少女生殖健康教育中的差距。
PLoS One. 2018 Nov 6;13(11):e0206102. doi: 10.1371/journal.pone.0206102. eCollection 2018.
8
The role of levonorgestrel intrauterine systems in the treatment of symptomatic fibroids.左炔诺孕酮宫内节育系统在治疗有症状子宫肌瘤中的作用。
Prz Menopauzalny. 2017 Dec;16(4):129-132. doi: 10.5114/pm.2017.72758. Epub 2017 Dec 30.
9
Intrauterine devices at six months: does patient age matter? Results from an urban family medicine federally qualified health center (FQHC) network.六个月时的宫内节育器:患者年龄有影响吗?来自城市家庭医学联邦合格健康中心(FQHC)网络的结果。
J Am Board Fam Med. 2014 Nov-Dec;27(6):822-30. doi: 10.3122/jabfm.2014.06.140091.
10
Understanding benefits and addressing misperceptions and barriers to intrauterine device access among populations in the United States.了解美国人群使用宫内节育器的益处,并消除误解和障碍。
Patient Prefer Adherence. 2014 Jul 3;8:947-57. doi: 10.2147/PPA.S45710. eCollection 2014.